The mutation causing myotonic dystrophy (DM) has recently been identified as an unstable CTG trinucleotide repeat located in the 3' untranslated region of a gene encoding for a protein with putative serine-threonine protein kinase activity. In this report we present the genomic sequences of the human and murine DM kinase gene. A comparison of these sequences with each other and with known cDNA sequences from both species, led us to predict a translation initiation codon, as well as determine the organization of the DM kinase gene. Several polymorphisms within the human DM kinase gene have been identified, and PCR assays to detect two of these are described. The complete sequence and characterization of the structure of the DM kinase gene, as well as the identification of novel polymorphisms within the gene, represent an important step in a further understanding of the genetics of myotonic dystrophy and the molecular biology of the gene.
INTRODUCTION
Myotonic dystrophy (DM) is the most prevalent inherited neuromuscular disease in adults (1) . The DM mutation, localized to the long arm of human chromosome 19 (19ql3.3) , has recently been identified as an unstable trinucleotide CTG repeat in the 3' untranslated region of a gene encoding for a protein with putative serine-threonine protein kinase activity (2) (3) (4) . Although quite polymorphic, the CTG repeat is both meiotically and mitotically stable in the normal population. In affected individuals, the repeat exhibits instability with copy number ranging from a minimum of approximately 50 to greater than 2000 (2) . Increasing amplification of the CTG repeat is correlated with increased disease severity (2, 5, 6) . In all populations studied thus far, the amplification of the CTG repeat seems to be the sole mutation responsible for DM (2, 7, 8) ; with the rare exception, in one study, of two clinically affected families which exhibit no amplification of the trinucleotide repeat (2) .
The sequence of the coding region of the DM kinase gene, determined from clones isolated from heart, brain and muscle cDNA libraries, has been reported by various groups (3, 4, 9) . All of the sequences were missing the initiation codon. The translational products deduced from the various sequences have also differed, but clearly have domains coding for a serinethreonine protein kinase in all cases. Recently, we reported on the characterization of the DM region in both the human and mouse genomes, and have provided clear evidence for a variety of alternatively spliced mRNAs encoding the DM kinase, in both species (9) .
In this report, we present the complete genomic sequence and structure of the human DM kinase gene, starting with the sequence of the 3' end of the DMR-N9 gene, which is immediately telomeric to the DM kinase gene (9) . Most of the genomic sequence of the murine gene, with the exception of some intron sequences, was also determined. Precise sequences for intron and exon boundaries of all known exons of the DM kinase in both mouse and human genomes are described. As well, the genomic sequence of the 5' end of the DM kinase gene from both species, and the location of a putative translational start site are presented. Furthermore, the position of several polymorphisms within the human DM kinase gene and polymerase chain reaction (PCR) based assays to detect two of them are detailed. These polymorphisms will be very useful in studying the linkage disequilibrium patterns of these markers with respect to the DM mutation. The sequence information should be useful in further characterization of the DM kinase as well as be of great value in detecting possible, additional mutations within the gene.
RESULTS AND DISCUSSION
To determine the structure and genomic sequence of the human DM kinase gene, a detailed restriction map of the relevant regions of the chromosome 19 cosmid clones Yal00263 and F18894 (10), was obtained. Similarly, the relevant regions of the mouse genome were mapped (9) . The DM kinase gene mapped within a region of approximately 14 kb contained within five contiguous BamHI fragments in cosmid Ya 100263 (Figure 1 ). most telomeric BamHI site of the five BamHI fragments and ends at the position of the poly A tail of the cDNA. It contains the sequence of the last exon of DMR-N9, and all of the DM kinase gene. Except for the presence of two Alu repeats preceding exon 9 and three Alu repeats following it, the rest of the sequence is unique. In order to ascertain the putative translational start site of the DM kinase gene, we did a comparative analysis of the sequences from the 5' region of the murine and human versions of the gene (Figure 2 ). The sequence depicted in Figure 2 terminates at the last base of the first exon of the DM kinase gene. The last 92 bp or 31 codons overlap with the sequence of the 5' end of the Note. Exon 8a, a shortened version of exon 8b, is generated by the use of a cryptic splice site within the exon and results in the loss of the last five codons (15 bp). The clone containing this alternatively spliced exon was isolated from a human brain frontal cortex cDNA library. The nucleotide position starts from the putative transcriptional start site of the DM kinase gene. This is position 1394 of the submitted sequence (GenBank accession no. LO8835). A schematic of the various spliced regions of the human gene is presented in Figure 3A .
longest cDNA reported for the human DM kinase gene (9) . The longest reported murine cDNA began in exon four (9) , but new cDNA clones as well as murine genomic clones spanning the first three exons have since been isolated and sequenced. At the 3' end of the sequence presented in Figure 2 , the strong sequence homology between species was clearly evident. In the 5' region of the sequence, the sequence homology, though present, was scattered with sequence gaps and base deletions. Therefore, due to the loss of sequence homology and the known proximity of the DMR-N9 gene (9), the putative translational start codon was identified, based upon the maintenance of the open reading frame for cDNAs previously identified in both species. The sequences flanking the translational start site (CCAACATGT), though not identical, are similar to the Kozak consensus sequence (CC-A/GCCAUGG) (11) . A computer search of the sequences revealed no clear TATA or CAAT box motifs in either species.
The predicted translational product of 629 amino acids, for the longest human cDNA, has a molecular weight of 69,370 Daltons. A computer search for binding sites of transcription factors identified a variety of putative sites (including a metal responsive element (MRE CS4) (12), Spl, API, AP2 binding sites and CAP sites (13) ) in the sequence depicted in Figure 2 . Ongoing studies in our laboratories to detect promoter activity within the 5' region of the human DM kinase gene, have mapped putative transcriptional start sites. In the human situation, the transcriptional start site of the DM kinase gene may in fact be 5' to an unusual stretch of 24 adenines located approximately 550 bp proximal to the start codon (Figure 2 ). This transcription initiation site is actually within the 3' untranslated region of a cDNA clone isolated for the human DMR-N9 gene (though this clone could represent a readthrough mRNA, as it has been suggested that the polyadenylation signals of the DMR-N9 gene may be used inefficiently) (9) . The predicted full length mRNA of the human gene would be approximately 3.4 kb. These results are concordant with previously reported data from Northern blot analysis (3,9) which showed that the full length transcript was between 3 to 3.3 kb. Future studies, utilizing this sequence, will Afore. An 87 bp segment (encoding amino acids 328 to 356) within the longer versions of exon 8 (8a and 8b) is deleted in some murine isoforms (9) . This fragment, which extends the homology to protein kinases, is flanked by consensus 5' (GAG/gtggg) and 3' (accag/ACT) splice junctions. Exon 14 utilizes two different 3' splice junctions. The longer version (14b), found in some cDNA clones, results in the use of an earlier translational stop codon. The shorter version (14a), though similar to the human version of exon 14, has the 3' splice junction offset by 4 bp, thus resulting in a different 3' termini for the translated product. The intron between exons 12 and 13 was present in some cDNA clones. This resulted in a different and shorter 3' end for the translated product. A schematic of the various spliced regions and translational stop sites of the murine gene is presented in Figure 3B . *Exons with nonconsensus 5' splice junctions. clarify the importance of the 5' region with respect to the expression of the DM kinase gene and factors controlling it.
The precise positions of intron-exon boundaries were determined by comparison of the genomic and cDNA sequences ( Table 1 ). The human gene has fifteen exons, varying in size from 47 bp to 936 bp. The introns vary in size from 2331 bp (the first intron), to 76 bp (the seventh intron). The highly conserved kinase domain is encoded by exons 2 through 8. A region showing significant homology to the a-helical (coiled-coil) domains of myofibrillar and filamentous proteins is encoded by exons 9 through 12, with the strongest homology being contained in exons 11 and 12. Exon 15, the last exon, contains a relatively short region encoding for a hydrophobic, possibly transmembranous domain, and also contains the CTG repeat in the 3' untranslated region. Exons 13 and 14, which show no strong homology to any proteins or protein domains, are alternatively spliced out in several cDNA clones isolated from a human heart cDNA library. As a consequence of a shift in the open reading frame, an earlier termination codon (5 bp after the beginning of exon 15) is used. This results in the loss of the hydrophobic region. The predicted translational product of this isoform has 535 amino acids with a molecular weight of 59,790 Daltons. A schematic of the various human isoforms is presented in Figure 3A .
The presence of multiple protein-isoform encoding mRNAs has been well documented (9) . Though the genomic sequence of the murine DM kinase gene is incomplete due to gaps in some intron regions, we were able to determine the sequences of all known splice junctions for the gene, in the mouse genome (Table  2 ) (EMBL accession nos Z21503-Z21506 (incl.)). It is clear that the myriad of alternatively spliced mRNAs ( Figure 3B ) isolated from a mouse brain cDNA library resulted from the use of cryptic splice sites. In the mouse, nonconsensus 5' splice junctions (exons 12) are used in some cDNA clones. Also a comparison of the genomic sequence between species, identified nucleotide changes in the human situation, which have led to a loss of the consensus 3' splice junction utilized by the mouse to generate alternatively spliced mRNAs containing exon 14 or deleting an 87 bp fragment in exon 8. Interestingly, only one human cDNA clone, which has the last five codons of exon 8 deleted by the use of an alternate 5' splice junction within the exon, showed the use of cryptic splice sites. This clone was isolated from a human brain frontal cortex library. A similar clone has been isolated from a mouse brain cDNA library.
In the course of sequencing the human gene, numerous sequence polymorphisms were identified within introns and noncoding regions of the gene (Table 3) . No polymorphisms have been identified within the coding region thus far. The majority of these sequence polymorphisms are due to a single base change. For those which have altered a restriction enzyme recognition sequence and were amenable to simple detection, we have developed PCR based assays (Figure 4) . The larger of two alleles for the Hhal polymorphism ( fig. 4A ) located in the fifth intron, has an allelic frequency of 0.55. Of the two alleles detected by the Hinfl polymorphism ( fig. 4B ) located in the ninth intron, the larger allele has an allelic frequency of 0.47. Also, a 1 kb insertion/deletion polymorphism, previously noted to be in total linkage disequilibrium with the DM mutation (2, 7, 8) , has been characterized and a PCR based assay to detect this flanking marker has been developed (14) . The larger of these two alleles, on which the DM mutation always occurs, is found in 53% of normal chromosomes. This polymorphism is contained within the region of the two Alu repeats that precede exon 9. We have utilized all of these polymorphisms, as the primary tools in documenting a rare gene conversion event which resulted in the loss of the DM mutation in an offspring who inherited the DM chromosome from her affected father (15) . The polymorphisms should be of significant value in studying linkage disequilibrium patterns in the region of the DM mutation, and may assist in determining the ancestry of the DM mutation in various populations.
The determination of the complete genomic sequence and the structure of the DM kinase gene represents an important initial step in further characterization of the gene and a better understanding of the disease. Presently, it is unclear how the presence of an unstable trinucleotide CTG repeat in the 3' untranslated region of a gene encoding a kinase could result in the clinical outcome of myotonic dystrophy, an autosomal dominant disorder. No clear evidence has been provided to indicate that the product of the DM kinase gene is the affected protein in DM, though the expression patterns of the gene (9) suggest it is the most likely candidate. The presence of a gene (DMR-N9) expressed in brain and testes (9) in the immediate vicinity of the DM kinase gene, along with speculation on the effects of the unstable CTG repeat on neighbouring genes and chromosomal structure, has led to suggestions that multiple genes are involved in the clinical manifestation of DM.
The amplification of the CTG trinucleotide repeat has been identified as the mutation responsible for DM in over 98% of affected families (2) . The provision of the complete sequence of the gene is essential for the detection of novel mutations within the DM kinase gene in the few affected families which demonstrate no amplification of the CTG repeat. This would prove that deleterious effects on this one gene are solely responsible for DM. Also, it would lead to a better understanding of the functional importance of the various domains in the gene and may provide ideas for therapeutic strategies to treat DM. The elucidation of the structure and sequence of the DM kinase gene will aid in the development of in vitro and transgenic models. These models can be used to study the effects of the unstable CTG repeat in DM, as well as gain a broader understanding of the properties of heritable amplified trinucleotide repeats, which have now been clearly implicated in three major genetic disorders (2) (3) (4) 16, 17) .
MATERIALS AND METHODS

DNA mapping and sequencing
The isolation and detection of chromsome 19 cosmid and yeast artificial chromosome (YAC) clones, as well as the characterization of cDNA clones, have been detailed elsewhere (9, 10) . Restriction maps of the relevant regions of cosmids YalOO263 and F18894, as well as mouse genomic DNA (9), were generated after hybridization with the cDNA clones. Appropriate subclones of mouse and human genomic DNA were generated for sequence analysis. As well, a shotgun cloning strategy was used to generate clones from cosmid Yal00263. Also, PCR amplified products of human genomic DNA were directly sequenced to confirm much of the sequence generated from the clones. Sequencing strategies included the direct sequencing of subclones with vector primers, sequencing with synthesized oligonucleotides, and sequencing of a graded series of clones with increasing deletions from the 5' end, generated by exonuclease III treatment. Sequencing was performed using standard protocols with 35 S and 32 P labeled dNTPs. In addition, sequencing was performed with an ABI 373A automated sequencer using either fluorescent dye labeled primers, or dideoxytermination sequencing reactions with fluorescent dye labeled oliogonueleotides. Assembly, analysis and alignment of DNA sequences was done with the IG-SUITE 5.35 package (Intelligenetics). David Ghosh's Transcription Factor Database (Rel. 4.5) (18) was scanned using SINGAL SCAN 3.0 (19) . As well, the sequence alignment was done using the GAP program in the GCG package (20) .
PCR based assays of polymorphisms Hhal polymorphism. Genomic DNA (2^g) was PCR amplified with 50 ng each of primers 445 (5' GACCTGCTGACACTGCTGAGC 3') and primer 472 (5' GTGCCTTCCATCCCTCATCAG 3') by a standard protocol and 30 cycles of amplification at 94°C for 1 min., 60°C for 1.5 min., and 72°C for 1.5 min. Amplified products were digested with Hhal for one hour, and subsequently separated by electrophoresis, using 1 xTBE buffer,in 1 % agarose, 1 % NuSieve gels containing ethidium bromide.
Hinfl polymorphism. Genomic DNA (2/tg) was PCR amplified with 50 ng each of primers 458 (5' CTGCAGAAGGTTTAGAAAGAGC 3') and primer 424 (5' CATCCTGTGGGGACACCGAGG 3') by a standard protocol and 10 cycles of amplification at 94°C for 1 min., 60°C for 1.5 min., and 72°C for 1.5 min. followed by 25 cycles of amplification at 94°C for 1 min., 55°C for 1.5 min., and 72°C for 1.5 min. Amplified products were digested with Hinfl for one hour, and subsequently separated by electrophoresis, using 1 xTBE buffer, in 1% agarose, 2% NuSieve gels containing ethidium bromide.
